FundedIQ
Biotechnology

Corner Therapeutics: Funding, Investors & Team (Oct 2026)

Corner Therapeutics is a biotechnology company focused on research in the field of immunotherapy.

cornertx.com LinkedIn Watertown, United States 11-50 employees
Total raised
$54.0M
Rounds
1
Latest
Series A
Apr 2024

Corner Therapeutics has raised $54.0M across 1 funding round on record, the most recent a Series A of $54.0M announced in Apr 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Corner Therapeutics Company Profile and Key Stats

Total funding raised
$54.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$54.0M in Apr 2024
Employees
11-50
reported band
Headquarters
Watertown, United States

Latest funding round on record: Apr 2024.

Corner Therapeutics Funding Rounds

Date
Round
Amount
Series A
$54.0M

Corner Therapeutics Founders and Leadership Team

Name
Role
Contact
Jonathan Kagan
Founder
—

No contact details are on record for this team yet.

Corner Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Corner Therapeutics' latest round of $54.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Corner Therapeutics in Biotechnology and Watertown

Companies Similar to Corner Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Corner Therapeutics Funding FAQs

What does Corner Therapeutics do?

Corner Therapeutics is a biotechnology company focused on research in the field of immunotherapy.

How much funding has Corner Therapeutics raised?

Corner Therapeutics has raised $54.0M across 1 round on record. The most recent is a Series A of $54.0M announced in Apr 2024.

When did Corner Therapeutics last raise funding?

Corner Therapeutics' most recent funding round on record is a Series A of $54.0M, announced in Apr 2024.

Who founded Corner Therapeutics?

FundedIQ lists Jonathan Kagan (Founder) at Corner Therapeutics.

Where is Corner Therapeutics headquartered?

Corner Therapeutics is based in Watertown, Massachusetts, United States.

How many employees does Corner Therapeutics have?

Corner Therapeutics is in the 11-50 employee band.

How does Corner Therapeutics' funding compare to other Biotechnology startups?

Corner Therapeutics' latest round of $54.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Corner Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Corner Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.